Skip to main content
. 2024 Feb 29;13:26. doi: 10.1186/s13756-024-01374-9
Identified gaps
The development of improved test methodologies to evaluate the in-vivo efficacy of ABHR that accurately reflects clinical use, and the use of contamination techniques that align with hand contamination patterns in clinical settings.
Selection of test organisms with high environmental stability and hand-transmissibility.
Laboratory studies utilizing adapted test methodologies, to demonstrate sufficient in-vivo efficacy of ABHR.